Protein kinases play a crucial role in the pathogenesis of inflammatory bowel disease(IBD), the two main forms of which are ulcerative colitis and Crohn's dis-ease. In this article, we will review the mechanisms o...Protein kinases play a crucial role in the pathogenesis of inflammatory bowel disease(IBD), the two main forms of which are ulcerative colitis and Crohn's dis-ease. In this article, we will review the mechanisms of involvement of protein kinases in the pathogenesis of and intervention against IBD, in terms of their effects on genetics, microbiota, mucous layer and tight junc-tion, and the potential of protein kinases as therapeutic targets against IBD.展开更多
目的探讨死亡相关蛋白激酶(death-associate dprotein kinase,DAPK)基因甲基化与胃癌的关系。方法采用甲基化特异性PCR(methylation specific PCR,MSP)检测38例配对胃癌组织、癌旁正常组织和转移淋巴结中DAPK基因甲基化的情况。结果81.6...目的探讨死亡相关蛋白激酶(death-associate dprotein kinase,DAPK)基因甲基化与胃癌的关系。方法采用甲基化特异性PCR(methylation specific PCR,MSP)检测38例配对胃癌组织、癌旁正常组织和转移淋巴结中DAPK基因甲基化的情况。结果81.6%(31/38)的胃癌组织中存在异常甲基化,而相应的癌旁正常组织和转移淋巴结中该基因的甲基化率分别为42.1%(16/38)和70.2%(27/38)。癌组织和转移淋巴结中DAPK基因甲基化的发生率显著高于癌旁正常组织。癌旁正常组织中,该基因甲基化与年龄相关,P=0.020。但与肿瘤大体类型、分化程度及浸润深度等临床病理特征无关。结论DAPK基因异常甲基化是胃癌发生发展过程中的频发事件,通过检测胃黏膜组织及转移淋巴结中该基因的甲基化情况,可能会对胃癌的诊断及判断淋巴结的微转移提供一定的参考价值,并有望成为胃癌新的基因治疗靶点。展开更多
回顾性分析15例CD30+间变性大细胞淋巴瘤(anaplastic large cell lymphoma,ALCL)患者的临床资料。中位年龄36岁,男女比例为1.5∶1。所有病例均经病理证实,均以联合化疗为主,配合局部病灶野放疗3例。化疗方案主要为CHOP、CVAD和BACOP,以C...回顾性分析15例CD30+间变性大细胞淋巴瘤(anaplastic large cell lymphoma,ALCL)患者的临床资料。中位年龄36岁,男女比例为1.5∶1。所有病例均经病理证实,均以联合化疗为主,配合局部病灶野放疗3例。化疗方案主要为CHOP、CVAD和BACOP,以CHOP方案为主。有B症状、Ⅲ～Ⅳ期和结外侵犯者分别为60.0%(9/15)、73.3%(11/15)和60.0%(9/15);乳酸脱氢酶升高者为46.7%(7/15);间变性大细胞淋巴瘤激酶阳性9例(60.0%),阴性6例(40.0%)。CR 11例(73.3%),PR 1例(6.7%),SD+PD 3例(20.0%)。展开更多
基金Supported by The Program for Zhejiang Leading Team of Science and Technology Innovation,No.2011R50021
文摘Protein kinases play a crucial role in the pathogenesis of inflammatory bowel disease(IBD), the two main forms of which are ulcerative colitis and Crohn's dis-ease. In this article, we will review the mechanisms of involvement of protein kinases in the pathogenesis of and intervention against IBD, in terms of their effects on genetics, microbiota, mucous layer and tight junc-tion, and the potential of protein kinases as therapeutic targets against IBD.
文摘目的探讨死亡相关蛋白激酶(death-associate dprotein kinase,DAPK)基因甲基化与胃癌的关系。方法采用甲基化特异性PCR(methylation specific PCR,MSP)检测38例配对胃癌组织、癌旁正常组织和转移淋巴结中DAPK基因甲基化的情况。结果81.6%(31/38)的胃癌组织中存在异常甲基化,而相应的癌旁正常组织和转移淋巴结中该基因的甲基化率分别为42.1%(16/38)和70.2%(27/38)。癌组织和转移淋巴结中DAPK基因甲基化的发生率显著高于癌旁正常组织。癌旁正常组织中,该基因甲基化与年龄相关,P=0.020。但与肿瘤大体类型、分化程度及浸润深度等临床病理特征无关。结论DAPK基因异常甲基化是胃癌发生发展过程中的频发事件,通过检测胃黏膜组织及转移淋巴结中该基因的甲基化情况,可能会对胃癌的诊断及判断淋巴结的微转移提供一定的参考价值,并有望成为胃癌新的基因治疗靶点。
